Home › Funds › GUGGENHEIM CAPITAL LLC › ABBV

GUGGENHEIM CAPITAL LLC position in ABBV

ABBVIE INC · Health Care

GUGGENHEIM CAPITAL LLC reported holding 234,277 shares of ABBV (ABBVIE INC) in its Q2 2026 13F filing — a position valued at US$59.0M, representing 0.38% of its reported portfolio and ranking #43 among its reported holdings. GUGGENHEIM CAPITAL LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)234.28K sh
Reported value held$58.95M
Portfolio Weight0.38%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GUGGENHEIM CAPITAL LLC's ABBV position evolved

GUGGENHEIM CAPITAL LLC first disclosed a stake in ABBV in Q3 2023 at 352,299 shares (US$52.5M). The position peaked in Q4 2025 at 265,205 shares, worth US$60.6M. Across 12 filings, GUGGENHEIM CAPITAL LLC increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 234,277 shares valued at US$59.0M — a reduction of -11,424 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 352.30K $52.51M New
Q4 2023 298.50K $46.26M Reduce
Q1 2024 314.69K $57.30M Add
Q2 2024 297.51K $51.03M Reduce
Q3 2024 278.53K $55.00M Reduce
Q4 2024 256.08K $45.51M Reduce
Q1 2025 244.51K $51.23M Reduce
Q2 2025 243.29K $45.16M Hold
Q3 2025 252.28K $58.41M Add
Q4 2025 265.20K $60.60M Add
Q1 2026 245.70K $53.44M Reduce
Q2 2026 234.28K $58.95M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has GUGGENHEIM CAPITAL LLC held ABBV?

GUGGENHEIM CAPITAL LLC has disclosed ABBV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is GUGGENHEIM CAPITAL LLC's current position in ABBV?

As of Q2 2026, GUGGENHEIM CAPITAL LLC holds 234.28K shares of ABBV (ABBVIE INC), valued at $58.95M, representing 0.38% of its reported portfolio and ranking #43.

Has GUGGENHEIM CAPITAL LLC been buying or selling ABBV?

In the latest 13F filing (Q2 2026), GUGGENHEIM CAPITAL LLC reduced its position in ABBV. The position peaked in Q4 2025 at 265.20K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.